$15.37
-0.04 (-0.26%)
Open$15.33
Previous Close$15.41
Day High$15.60
Day Low$15.11
52W High$23.57
52W Low$1.62
Volume—
Avg Volume472.1K
Market Cap468.57M
P/E Ratio15.71
EPS$2.29
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+81.8% upside
Current
$15.37
$15.37
Target
$27.94
$27.94
$24.18
$27.94 avg
$39.76
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 133.03M | 8.10M | 7.51M |
| Net Income | 73.83M | -2,253,266 | -2,377,750 |
| Profit Margin | 55.5% | -27.8% | -31.6% |
| EBITDA | 38.85M | -3,375,106 | -3,186,219 |
| Free Cash Flow | — | -1,035,116 | -1,228,536 |
| Rev Growth | +155.8% | +18.0% | -0.1% |
| Debt/Equity | 2.29 | 0.78 | 0.76 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |